Första AP-fonden’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,249,000
| Closed | -$31.1M | – | 379 |
|
|
2025
Q4 | $31.1M | Sell |
1,249,000
-131,200
| -10% | -$3.31M | 0.19% | 98 |
|
|
2025
Q3 | $35.2M | Buy |
1,380,200
+96,100
| +7% | +$2.37M | 0.21% | 84 |
|
|
2025
Q2 | $31.1M | Sell |
1,284,100
-166,700
| -11% | -$3.89M | 0.2% | 87 |
|
|
2025
Q1 | $36.8M | Buy |
1,450,800
+67,300
| +5% | +$1.76M | 0.28% | 66 |
|
|
2024
Q4 | $36.7M | Sell |
1,383,500
-37,900
| -3% | -$1.03M | 0.26% | 66 |
|
|
2024
Q3 | $41.1M | Buy |
1,421,400
+138,800
| +11% | +$4.05M | 0.32% | 60 |
|
|
2024
Q2 | $35.9M | Sell |
1,282,600
-81,100
| -6% | -$2.23M | 0.32% | 55 |
|
|
2024
Q1 | $37.8M | Sell |
1,363,700
-233,000
| -15% | -$6.47M | 0.32% | 57 |
|
|
2023
Q4 | $46M | Buy |
1,596,700
+23,600
| +2% | +$713K | 0.46% | 37 |
|
|
2023
Q3 | $52.2M | Buy |
1,573,100
+49,900
| +3% | +$1.76M | 0.58% | 26 |
|
|
2023
Q2 | $55.9M | Buy |
1,523,200
+5,100
| +0.3% | +$199K | 0.6% | 26 |
|
|
2023
Q1 | $61.9M | Sell |
1,518,100
-137,900
| -8% | -$5.96M | 0.73% | 23 |
|
|
2022
Q4 | $84.9M | Buy |
1,656,000
+266,000
| +19% | +$12.8M | 0.96% | 16 |
|
|
2022
Q3 | $60.8M | Buy |
1,390,000
+301,600
| +28% | +$14.7M | 0.74% | 20 |
|
|
2022
Q2 | $57.1M | Buy |
1,088,400
+47,200
| +5% | +$2.41M | 0.74% | 22 |
|
|
2022
Q1 | $53.9M | Sell |
1,041,200
-123,000
| -11% | -$6.38M | 0.61% | 23 |
|
|
2021
Q4 | $68.7M | Buy |
1,164,200
+36,800
| +3% | +$1.82M | 0.69% | 18 |
|
|
2021
Q3 | $48.5M | Sell |
1,127,400
-15,200
| -1% | -$673K | 0.55% | 31 |
|
|
2021
Q2 | $44.7M | Buy |
1,142,600
+146,200
| +15% | +$5.69M | 0.53% | 33 |
|
|
2021
Q1 | $36.1M | Buy |
996,400
+21,200
| +2% | +$753K | 0.51% | 34 |
|
|
2020
Q4 | $35.9M | Buy |
975,200
+177,533
| +22% | +$6.51M | 0.54% | 35 |
|
|
2020
Q3 | $27.8M | Sell |
797,667
-84,004
| -10% | -$2.95M | 0.57% | 33 |
|
|
2020
Q2 | $27.4M | Buy |
881,671
+78,312
| +10% | +$2.66M | 0.72% | 23 |
|
|
2020
Q1 | $24.9M | Buy |
+803,359
| New | +$27.4M | 0.89% | 17 |
|
|
2019
Q4 | – | Sell |
-117,416
| Closed | -$4M | – | 317 |
|
|
2019
Q3 | $4M | Buy |
117,416
+23,083
| +24% | +$839K | 0.17% | 124 |
|
|
2019
Q2 | $3.88M | Sell |
94,333
-13,280
| -12% | -$527K | 0.17% | 120 |
|
|
2019
Q1 | $4.34M | Sell |
107,613
-2,846
| -3% | -$114K | 0.19% | 116 |
|
|
2018
Q4 | $4.58M | Sell |
110,459
-36,679
| -25% | -$1.52M | 0.22% | 103 |
|
|
2018
Q3 | $6.15M | Buy |
147,138
+116,467
| +380% | +$4.48M | 0.25% | 96 |
|
|
2018
Q2 | $1.06M | Sell |
30,671
-523,853
| -94% | -$17.9M | 0.04% | 242 |
|
|
2018
Q1 | $18.7M | Sell |
554,524
-14,124
| -2% | -$486K | 0.65% | 45 |
|
|
2017
Q4 | $19.5M | Buy |
568,648
+87,482
| +18% | +$2.98M | 0.71% | 43 |
|
|
2017
Q3 | $16.3M | Sell |
481,166
-149,668
| -24% | -$4.81M | 0.57% | 47 |
|
|
2017
Q2 | $20.1M | Sell |
630,834
-84,741
| -12% | -$2.67M | 0.56% | 50 |
|
|
2017
Q1 | $23.2M | Sell |
715,575
-69,354
| -9% | -$2.19M | 0.75% | 41 |
|
|
2016
Q4 | $24.2M | Sell |
784,929
-173,321
| -18% | -$5.29M | 0.78% | 42 |
|
|
2016
Q3 | $30.8M | Sell |
958,250
-660,085
| -41% | -$22.1M | 0.86% | 34 |
|
|
2016
Q2 | $54.1M | Buy |
+1,618,335
| New | +$51.7M | 1.57% | 18 |
|
|
2016
Q1 | – | Sell |
-1,524,166
| Closed | -$41.6M | – | 127 |
|
|
2015
Q4 | $41.6M | Buy |
+1,524,166
| New | +$47.9M | 1.33% | 24 |
|
Other funds holding PFE
Första AP-fonden's PFE Position: Q1 2026 in Review
Första AP-fonden sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,249,000 shares — an estimated $31.1M sold.
Första AP-fonden first reported a position in PFE in Q4 2015 and held it in 39 quarters. The position peaked at $84.9M in Q4 2022. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Första AP-fonden reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Första AP-fonden sold 1,249,000 Pfizer shares in Q1 2026, an estimated $31.1M.
- Första AP-fonden first reported a position in Pfizer in Q4 2015 and held it in 39 quarters.
- Första AP-fonden's Pfizer position peaked at $84.9M in Q4 2022.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Första AP-fonden's 13F filing for Q1 2026.